The Valley Desk

NCT02959970 · Interventional trial

Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

Overall registry status Completed

Phase 4

Conditions Acne Vulgaris

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov